Based on the expression levels of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), breast cancer patients could be classified into 4 subtypes: Luminal A, Luminal B, HER2 enriched and triple negative (TN). Here, PGR is linked to breast cancer.